A long-acting contraceptive implant such as
Implanon has the advantage over oral contraceptive
pills in terms of overcoming reduced contraceptive
efficacy due to user failure (missed tablet) and of
being independent compliance (no daily tablet intake).
But like other progestogen contraceptives, Implanon
is associated with bleeding disturbance and this could
affect its acceptability. The study aims to determine
the continuation of Implanon during the first year of
use and evaluate its adverse events during the first
three months after administration.